| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-82 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 |
| filingDate |
2005-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a807125637679a799211de4d876824
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c064d391008e6e6ea1f603a7dc781c |
| publicationDate |
2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005165090-A1 |
| titleOfInvention |
Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation |
| abstract |
A method and pharmaceutical composition for treating the bladder cancer in a mammal includes intravesically administrating to a mammal in need of bladder cancer treatment a therapeutically effective amount of a composition comprising at least one polyphenol and in particular EGCG, within the mammal's bladder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8128967-B2 |
| priorityDate |
2004-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |